Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by westcoast1000on Jun 08, 2023 3:27pm
191 Views
Post# 35487095

Ongoing prevarication and misdirection

Ongoing prevarication and misdirectionSunday movies seems not to read or pay attention to anything before blathering the same misleading story.

To repost from a few days back:

Sunday Movies does not seem to read much here.

Like I said, Pfizer selected the CI because they owned it then. This is not a stupid company. Why the drivel continues is hard to say. 

And as I noted in another posts, clinical research ethics boards (a topic with which I am familar) would be vary hesitant if not downright hostile to not letting people leave a trial when they become ill from the treatment if they have metastic cancer. Finally people with liver or kidney mets would likely not be able to take most NSAIDS.

So there you have it folks. SM seems to like to complain, call people stupid, and denounce management and yet cannot read factual statements or write lucid sentences.




<< Previous
Bullboard Posts
Next >>